RA Capital Management, L.P. 13D and 13G filings for Werewolf Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 6:09 pm Purchase | 2025-05-12 | 13D | Werewolf Therapeutics, Inc. HOWL | RA Capital Management, L.P. | 6,746,807 15.000% | 553,926 (+8.94%) | Filing |
| 2024-05-07 4:52 pm Purchase | 2024-05-03 | 13D | Werewolf Therapeutics, Inc. HOWL | RA Capital Management, L.P. | 6,192,881 14.200% | 13,846 (+0.22%) | Filing |
| 2024-02-14 5:17 pm Purchase | 2024-02-12 | 13D | Werewolf Therapeutics, Inc. HOWL | RA Capital Management, L.P. | 6,179,035 15.200% | 2,210,452 (+55.70%) | Filing |
| 2021-05-06 4:33 pm Purchase | 2021-05-04 | 13D | Werewolf Therapeutics, Inc. HOWL | RA Capital Management, L.P. | 3,968,583 14.400% | 3,968,583 (New Position) | Filing |